Beta Bionics, Inc. (NASDAQ:BBNX) Receives $24.83 Consensus Target Price from Brokerages
Shares of Beta Bionics, Inc. (NASDAQ:BBNX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating […]
Shares of Beta Bionics, Inc. (NASDAQ:BBNX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating […]
